Evidence mapPaperPMID 36834337Full record

ArticleInternational journal of environmental research and public health2023

DNA-Methylation Signatures of Tobacco Smoking in a High Cardiovascular Risk Population: Modulation by the Mediterranean Diet.

Rebeca Fernández-Carrión, José V Sorlí, Eva M Asensio, Eva C Pascual, Olga Portolés, Andrea Alvarez-Sala, Francesc Francès, Judith B Ramírez-Sabio, Alejandro Pérez-Fidalgo, Laura V Villamil and 5 more

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Rebeca Fernández-CarriónDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0001-7738-5111
José V SorlíDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0002-0130-2006
Eva M AsensioDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0003-4558-0988
Eva C PascualDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
Olga PortolésDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
Andrea Alvarez-SalaDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0002-2988-1038
Francesc FrancèsDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
Judith B Ramírez-SabioOncology Service, Sagunto Hospital, 46520 Valencia, Spain.
Alejandro Pérez-FidalgoDepartment of Medical Oncology, University Clinic Hospital of Valencia, 46010 Valencia, Spain.ORCID 0000-0003-3568-4345
Laura V VillamilDepartment of Physiology, School of Medicine, University Antonio Nariño, Bogotá 111511, Colombia.
Francisco J TinahonesCIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Ramon EstruchCIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0003-1260-4445
Jose M OrdovasCIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Oscar ColtellCIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-4518-8495
Dolores CorellaDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0002-2366-4104

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biomarkers based on DNA methylation are relevant in the field of environmental health for precision health. Although tobacco smoking is one of the factors with a strong and consistent impact on DNA methylation, there are very few studies analyzing its methylation signature in southern European populations and none examining its modulation by the Mediterranean diet at the epigenome-wide level. We examined blood methylation smoking signatures on the EPIC 850 K array in this population (n = 414 high cardiovascular risk subjects). Epigenome-wide methylation studies (EWASs) were performed analyzing differential methylation CpG sites by smoking status (never, former, and current smokers) and the modulation by adherence to a Mediterranean diet score was explored. Gene-set enrichment analysis was performed for biological and functional interpretation. The predictive value of the top differentially methylated CpGs was analyzed using receiver operative curves. We characterized the DNA methylation signature of smoking in this Mediterranean population by identifying 46 differentially methylated CpGs at the EWAS level in the whole population. The strongest association was observed at the cg21566642 (

Indexed as

Cardiovascular DiseasesDiet, MediterraneanCpG IslandsDNADNA MethylationEpigenesis, GeneticGenome-Wide Association StudyHeart Disease Risk FactorsHumansRisk FactorsTobacco SmokingDNAdietary modulationDNA methylationepigenetic biomarkersEWASMediterranean dietprecision healthtobacco smoking

Identifiers

PMID36834337
PMCPMC9964856

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.